Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
South Korea
· Delayed Price · Currency is KRW 3,970.00
-410.00 (-9.36%)
Jan 17, 2025, 9:00 AM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 159.57 billion as of January 22, 2025. Its market cap has increased by 123.88% in one year.
Market Cap
159.57B
Enterprise Value
139.60B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,970.00
Market Cap Chart
Since March 22, 2021, Bridge Biotherapeutics's market cap has decreased from 300.48B to 159.57B, a decrease of -46.90%. That is a compound annual growth rate of -15.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 159.57B | -1.73% |
| Dec 30, 2024 | 162.38B | 102.52% |
| Dec 28, 2023 | 80.18B | -71.06% |
| Dec 29, 2022 | 277.06B | -17.02% |
| Dec 30, 2021 | 333.88B | 11.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 354.79T |
| SK hynix | 146.08T |
| LG Energy Solution | 86.70T |
| Samsung Biologics Co.,Ltd. | 72.24T |
| Hyundai Motor Company | 45.88T |
| Kia Corporation | 39.35T |
| Celltrion | 38.33T |
| KB Financial Group | 33.25T |